Total raised
$24.4M
Last: Undisclosed 2025-02
Stage
Series A
Founded
2009
Headcount
39
HQ
Caesarea
Sector
Health Tech & Life Sciences
About
CardiacSense has developed a watch for long-term, continuous monitoring of heart arrhythmias (such as atrial fibrillation or cardiac arrest) and blood pressure. The highly accurate CardiacSense watch is a medical wearable device cleared by the FDA and CE marked.
The CardiacSense watch enables big data analysis and AI-backed health care, providing 24/7 monitoring of vital signs.
The company is backed by a strong IP portfolio that includes developments in optics, mechanics, and signal processing.
Funding history · 9 rounds · $24.4M total
2025-02
Undisclosed
Undisclosed
2023-02
Undisclosed
Undisclosed
2023-01
Equity crowdfunding
Undisclosed
2022-03
Series A
$10.0M
2021-05
Seed
$7.0M
2019-02
Seed
$3.5M
2018-03
Seed
$1.4M
2017-10
Undisclosed
$500K
2016-12
Pre-Seed
$2.0M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient Remote MonitoringMedical DevicesMedical Monitors
Technologies
CommunicationsIOTSensingSemiconductors & ElectronicsSystem-on-a-chipArtificial Intelligence
Target customers
Healthcare & Life SciencesHealthcarePatientsProvidersInsurance Companies
Business model
B2B
Highlights
1 PatentsVerified
Tags
remote-monitoringbiosensorsdigital-healthcareblood-pressuremhealthmonitoringiotwearablereal-timeopticsmedical-devicessensorscardiologypatientshospitalsmedical-technologiesclinicsnon-invasiveinsurance-companiessystem-on-modulechips-designbig-datahome-careartificial-intelligencespace-techrespiratorychronic-patientsvital-signswearable